Sign in to view content

Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2021

Related

Number of Injections and Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER
Carl D. Regillo, MD
Annual Meeting Talks
2020
One-Year Results of Fluocinolone Acetonide Intravitreal Implant For Diabetic Macular Edema in Highly Treated Eyes
Sumit P. Shah, MD, FACS, FASRS
On Demand Cases, Courses, and Papers
2017
Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study
Dennis M. Marcus, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more